清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Effectiveness of different treatments for odontogenic keratocyst: a network meta-analysis

医学 剜除术 骨切除术 有袋化 外科 贾达德量表 角化囊肿 随机对照试验 科克伦图书馆 囊肿
作者
Essam Ahmed Al‐Moraissi,Amanpreet Kaur,Ricardo Santiago Gomez,Edward Ellis
出处
期刊:International Journal of Oral and Maxillofacial Surgery [Elsevier]
卷期号:52 (1): 32-43 被引量:25
标识
DOI:10.1016/j.ijom.2022.09.004
摘要

Odontogenic keratocysts (OKC) are benign but aggressive lesions. As there is a lack of well randomized clinical studies assessing the effectiveness of the different treatment options for OKC, a network meta-analysis (NMA) was performed to identify the best treatment option with the lowest recurrence rate. An electronic search was performed following the PRISMA guidelines to identify all clinical studies comparing treatment options against enucleation alone. The outcome variable was recurrence. The predictor variables were treatments. The eight included treatments were: enucleation with peripheral ostectomy/curettage (E + PO/curettage); enucleation with cryotherapy (E + CRYO); enucleation with/without PO followed by modified Carnoy's solution (E ± PO+MCS); enucleation with PO and with topical 5-fluorouracil (E + PO+5FU); enucleation with/without PO followed by original Carnoy's solution (E ± PO+CS); marsupialization alone (MARS); marsupialization followed by secondary enucleation with/without PO (MARS+2°E ± PO); and resection. The odds ratio was used to estimate the recurrence rate. A frequentist NMA was performed using Stata software. A total of 2989 patients in 40 studies were included. Both direct pairwise meta-analysis and NMA showed that E + 5FU+PO was significantly superior to E ± PO+MCS. However, no statistically significant difference was found between E ± PO+CS vs E + 5FU+PO, E ± PO+MCS, and resection, respectively (all very low quality evidence). The three most effective treatments in reducing the recurrence rate were E + PO+ 5FU (98.1%; very low quality evidence), resection (83.5%; very low quality evidence), and E ± PO+CS (63.8%; moderate quality evidence). The findings from this study suggest that CS remains the most effective fixative agent after enucleation and PO until proven otherwise. Additionally, 5FU appears to be an effective method with promising results that needs further research. Finally, the efficacy of MCS remains controversial; further in vivo and in vitro studies are required to determine new protocols. As this NMA included retrospective studies, the results should be interpreted with great caution (level of evidence: type III).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jasmine完成签到 ,获得积分10
15秒前
吉祥高趙完成签到 ,获得积分10
29秒前
小小果妈完成签到 ,获得积分10
33秒前
奶糖喵完成签到 ,获得积分10
35秒前
hbuhfl完成签到 ,获得积分10
43秒前
一彤展翅完成签到,获得积分10
46秒前
53秒前
xun发布了新的文献求助10
57秒前
ally完成签到,获得积分10
1分钟前
li完成签到 ,获得积分10
1分钟前
kenchilie完成签到 ,获得积分10
1分钟前
属实有点拉胯完成签到 ,获得积分10
1分钟前
apckkk完成签到 ,获得积分10
2分钟前
2分钟前
SciKid524完成签到 ,获得积分10
2分钟前
chemlixy完成签到 ,获得积分10
2分钟前
cstp完成签到,获得积分10
2分钟前
mark33442完成签到,获得积分10
2分钟前
小美酱完成签到 ,获得积分10
2分钟前
淡然藏花完成签到 ,获得积分10
3分钟前
苏su完成签到 ,获得积分10
3分钟前
完美梨愁完成签到 ,获得积分10
3分钟前
苗条的小蜜蜂完成签到 ,获得积分10
3分钟前
爱撒娇的紫菜完成签到,获得积分10
3分钟前
zhao完成签到,获得积分10
3分钟前
3分钟前
3分钟前
Kristina完成签到,获得积分10
3分钟前
雪山飞龙完成签到,获得积分10
3分钟前
小乙猪完成签到 ,获得积分0
3分钟前
赘婿应助科研通管家采纳,获得10
4分钟前
charliechen完成签到 ,获得积分10
4分钟前
有魅力荟完成签到,获得积分20
4分钟前
keyan完成签到 ,获得积分10
4分钟前
Connie完成签到,获得积分10
5分钟前
zhilianghui0807完成签到 ,获得积分10
5分钟前
QiaoHL完成签到 ,获得积分10
5分钟前
5分钟前
Yolo完成签到 ,获得积分10
5分钟前
方琼燕完成签到 ,获得积分10
5分钟前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Structural Load Modelling and Combination for Performance and Safety Evaluation 1000
Conference Record, IAS Annual Meeting 1977 820
電気学会論文誌D(産業応用部門誌), 141 巻, 11 号 510
Typology of Conditional Constructions 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3571317
求助须知:如何正确求助?哪些是违规求助? 3141926
关于积分的说明 9444838
捐赠科研通 2843331
什么是DOI,文献DOI怎么找? 1562830
邀请新用户注册赠送积分活动 731326
科研通“疑难数据库(出版商)”最低求助积分说明 718524